Paul F Truex's Net Worth
-$21.4 Thousand
Who is Paul F Truex?
Paul F Truex does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Trius Therapeutics Inc, CymaBay Therapeutics, Inc., Milestone Pharmaceuticals Inc., and Anthera Pharmaceuticals Inc.
SEC CIK
Paul F Truex's CIK is 0001120362
Past Insider Trading and Trends
2022 was Paul F Truex's most active year for acquiring shares with 5 total transactions. Paul F Truex's most active month to acquire stocks was the month of April. 2013 was Paul F Truex's most active year for disposing of shares, totalling 5 transactions. Paul F Truex's most active month to dispose stocks was the month of August. 2022 saw Paul F Truex paying a total of $143,795.12 for 81,780 shares, this is the most they've acquired in one year. In 2013 Paul F Truex cashed out on 63,403 shares for a total of $521,670.63, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Trius Therapeutics Inc No price found
InvestorPaul F Truex owns 13,270 units of Common Stock. In the year 2010 Paul F Truex filed a total of 8 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -11.27K |
—
|
—
|
0
|
Sep 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| +17.75% | 2K |
$6.80 | $13,600.00 | 13.27K |
Aug 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
| +287.82% | 8.36K |
$1.55 | $12,999.56 | 11.27K |
Nov 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CymaBay Therapeutics, Inc. (CBAY) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Milestone Pharmaceuticals Inc. (MIST) Snapshot price: $1.46
InvestorPaul F Truex owns 81,780 units of Common Shares which is worth $119,398.80. In the year 2019 Paul F Truex filed a total of 5 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 81.78K |
$1.76 | $143,795.12 | 81.78K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Anthera Pharmaceuticals Inc No price found
President and CEOPaul F Truex owns 11,845 units of Common Stock.acquired a total of 3,864 shares in Anthera Pharmaceuticals Inc, Paul also disposed a total of 8,974 shares of Anthera Pharmaceuticals Inc equalling to $29,614.20.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +1.25% | 1.14K |
$3.30 | -$8,989.20 | 92.03K |
Jun 30 - Mar 25
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||